F. V. D. Berkmortel

Abstract S1-03: First results from the multicenter phase III DATA study comparing 3 versus 6 years of anastrozole after 2-3 years of tamoxifen in postmenopausal women with hormone receptor-positive early breast cancer

C. Seynaeve, S. Linn, V. Tjan-Heijnen, 2017 .

A real-world study on implementation of bevacizumab in a cohort of HER2-negative metastatic breast cancer patients: A study of the Southeast Netherlands Breast Cancer Consortium

V. Tjan-Heijnen, N. Peters, M. Joore, 2017 .